PTEN and metabolic dysfunction-associated steatotic liver disease: The discoveries of BRUCE/PTEN dual deficiencies converging on STAT3 hyperactivation and STAT3 inhibition ameliorating MASH reveal mechanistic and therapeutic advance in MASLD/MASH.